Skin care regimen: a possible new standard of care for preventing rashes from anti-EGFR therapy.
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D005076:Exanthema / Q000139:chemically induced / Q000517:prevention & control*; D006801:Humans; D000077544:Panitumumab; D017592:Skin Care
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000077544:Panitumumab; D066246:ErbB Receptors